140 related articles for article (PubMed ID: 16322080)
1. Plasma metallothionein antibody and cadmium-induced renal dysfunction in an occupational population in China.
Chen L; Jin T; Huang B; Chang X; Lei L; Nordberg GF; Nordberg M
Toxicol Sci; 2006 May; 91(1):104-12. PubMed ID: 16322080
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between plasma anti-metallothionein antibody and renal dysfunction in cadmium exposed workers].
Chen L; Jin TY; Chang XL; Lei LJ; Zhou YF
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):7-11. PubMed ID: 16600085
[TBL] [Abstract][Full Text] [Related]
3. Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China.
Chen L; Jin T; Huang B; Nordberg G; Nordberg M
Toxicol Appl Pharmacol; 2006 Aug; 215(1):93-9. PubMed ID: 16510161
[TBL] [Abstract][Full Text] [Related]
4. Plasma metallothionein antibody, urinary cadmium, and renal dysfunction in a Chinese type 2 diabetic population.
Chen L; Lei L; Jin T; Nordberg M; Nordberg GF
Diabetes Care; 2006 Dec; 29(12):2682-7. PubMed ID: 17130205
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein I isoform mRNA expression in peripheral lymphocytes as a biomarker for occupational cadmium exposure.
Chang X; Jin T; Chen L; Nordberg M; Lei L
Exp Biol Med (Maywood); 2009 Jun; 234(6):666-72. PubMed ID: 19359654
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of exposure, effects and susceptibility in humans and their application in studies of interactions among metals in China.
Nordberg GF
Toxicol Lett; 2010 Jan; 192(1):45-9. PubMed ID: 19540908
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of kidney dysfunction in humans - relationship to cadmium dose, metallothionein, immunological and metabolic factors.
Nordberg GF; Jin T; Wu X; Lu J; Chen L; Lei L; Hong F; Nordberg M
Biochimie; 2009 Oct; 91(10):1282-5. PubMed ID: 19563860
[TBL] [Abstract][Full Text] [Related]
8. [Renal dysfunction in workers exposed to arsenic and cadmium].
Hong F; Jin TY; Lu GD; Yin ZY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Dec; 21(6):432-6. PubMed ID: 14761355
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein gene expression in peripheral lymphocytes and renal dysfunction in a population environmentally exposed to cadmium.
Lu J; Jin T; Nordberg G; Nordberg M
Toxicol Appl Pharmacol; 2005 Aug; 206(2):150-6. PubMed ID: 15967203
[TBL] [Abstract][Full Text] [Related]
10. Kidney dysfunction and cadmium exposure--factors influencing dose-response relationships.
Nordberg G; Jin T; Wu X; Lu J; Chen L; Liang Y; Lei L; Hong F; Bergdahl IA; Nordberg M
J Trace Elem Med Biol; 2012 Jun; 26(2-3):197-200. PubMed ID: 22565016
[TBL] [Abstract][Full Text] [Related]
11. Nephrotoxicity of repeated injections of cadmium-metallothionein in rats.
Wang XP; Chan HM; Goyer RA; Cherian MG
Toxicol Appl Pharmacol; 1993 Mar; 119(1):11-6. PubMed ID: 8470114
[TBL] [Abstract][Full Text] [Related]
12. Estimation of benchmark dose for pancreatic damage in cadmium-exposed smelters.
Lei LJ; Chen L; Jin TY; Nordberg M; Chang XL
Toxicol Sci; 2007 May; 97(1):189-95. PubMed ID: 17303580
[TBL] [Abstract][Full Text] [Related]
13. Increased hepatic and decreased urinary metallothionein in rats after cessation of oral cadmium exposure.
Liang Y; Li H; Xiang C; Lei L; Jin T; Nordberg M; Nordberg GF
Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):348-55. PubMed ID: 20030629
[TBL] [Abstract][Full Text] [Related]
14. [Application of metallothionein gene isoforms expression as biomarkers in cadmium exposure].
Chang XL; Jin TY; Chen L; Lei LJ; Zhou YF
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):12-5. PubMed ID: 16600086
[TBL] [Abstract][Full Text] [Related]
15. Estimation of benchmark dose for bone damage and renal dysfunction in a Chinese male population occupationally exposed to lead.
Sun Y; Sun D; Zhou Z; Zhu G; Lei L; Zhang H; Chang X; Jin T
Ann Occup Hyg; 2008 Aug; 52(6):527-33. PubMed ID: 18567606
[TBL] [Abstract][Full Text] [Related]
16. The reference dose for subchronic exposure of pigs to cadmium leading to early renal damage by benchmark dose method.
Wu X; Wei S; Wei Y; Guo B; Yang M; Zhao D; Liu X; Cai X
Toxicol Sci; 2012 Aug; 128(2):524-31. PubMed ID: 22610606
[TBL] [Abstract][Full Text] [Related]
17. The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden.
Vestergaard P; Shaikh ZA
Toxicol Appl Pharmacol; 1994 Jun; 126(2):240-7. PubMed ID: 8209377
[TBL] [Abstract][Full Text] [Related]
18. [Calculation of the combined renal dysfunction risk in patients co-exposed to arsenicum and cadmium by using benchmark dose method].
Hong F; Jin TY; Zhang AH
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):374-8. PubMed ID: 15569507
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein gene expression in peripheral lymphocytes from cadmium-exposed workers.
Lu J; Jin T; Nordberg G; Nordberg M
Cell Stress Chaperones; 2001 Apr; 6(2):97-104. PubMed ID: 11599580
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of MT-null mice to chronic CdCl2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex.
Liu J; Liu Y; Habeebu SS; Klaassen CD
Toxicol Sci; 1998 Nov; 46(1):197-203. PubMed ID: 9928683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
